Stericycle, Inc. (NASDAQ:SRCL), which is in the commercial services business, and is based in United States, saw significant share price movement during recent months on the NASDAQGS, rising to highs of $58.39 and falling to the lows of $44. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Stericycle’s current trading price of $45.7 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Stericycle’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
Is Stericycle still cheap?
Great news for investors – Stericycle is still trading at a fairly cheap price. My valuation model shows that the intrinsic value for the stock is $66.27, but it is currently trading at US$45.70 on the share market, meaning that there is still an opportunity to buy now. However, given that Stericycle’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.
Can we expect growth from Stericycle?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with a relatively muted revenue growth of 6.3% expected over the next couple of years, growth doesn’t seem like a key driver for a buy decision for Stericycle, at least in the short term.
What this means for you:
Are you a shareholder? Even though growth is relatively muted, since SRCL is currently undervalued, it may be a great time to increase your holdings in the stock. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.
Are you a potential investor? If you’ve been keeping an eye on SRCL for a while, now might be the time to enter the stock. Its future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy SRCL. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy.
Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Stericycle. You can find everything you need to know about Stericycle in the latest infographic research report. If you are no longer interested in Stericycle, you can use our free platform to see my list of over 50 other stocks with a high growth potential.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.